| # | Title | Journal | Year | Citations |
|---|
| 1 | Epidemiological trends in skin mycoses worldwide | Mycoses | 2008 | 933 |
| 2 | Molecular diagnostics of clinical strains of filamentous Basidiomycetes | Mycoses | 1998 | 479 |
| 3 | COVID‐19 associated pulmonary aspergillosis | Mycoses | 2020 | 434 |
| 4 | Hydrolytic enzymes as virulence factors of Candida albicans | Mycoses | 2005 | 419 |
| 5 | The changing face of epidemiology of invasive fungal disease in Europe | Mycoses | 2009 | 351 |
| 6 | The Clinical Pharmacokinetics of Itraconazole: An Overview | Mycoses | 1989 | 343 |
| 7 | Antifungal drug resistance among Candida species: mechanisms and clinical impact | Mycoses | 2015 | 314 |
| 8 | Trichosporon on humans: a practical account | Mycoses | 1994 | 248 |
| 9 | High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene | Mycoses | 2018 | 237 |
| 10 | An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital | Mycoses | 2018 | 236 |
| 11 | Antifungal activity of plant extracts against dermatophytes | Mycoses | 1999 | 223 |
| 12 | Epidemiology of tinea capitis in Europe: current state and changing patterns | Mycoses | 2007 | 217 |
| 13 | Aspergillus flavus: an emerging non‐fumigatus Aspergillus species of significance | Mycoses | 2009 | 217 |
| 14 | Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum | Mycoses | 1989 | 209 |
| 15 | Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study | Mycoses | 2013 | 198 |
| 16 | Chromoblastomycosis: clinical and mycologic experience of 51 cases | Mycoses | 2001 | 197 |
| 17 | COVID‐19‐associated mucormycosis: An updated systematic review of literature | Mycoses | 2021 | 185 |
| 18 | Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels | Mycoses | 1989 | 173 |
| 19 | Mucormycoses | Mycoses | 2001 | 171 |
| 20 | Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis | Mycoses | 2003 | 170 |
| 21 | In vitro efficacy of 75 essential oils against Aspergillus niger | Mycoses | 2006 | 164 |
| 22 | The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes—A molecular study | Mycoses | 2019 | 164 |
| 23 | Histoplasmosis: a review for clinicians from non-endemic areas | Mycoses | 2006 | 163 |
| 24 | High prevalence of foot diseases in Europe: results of the Achilles Project | Mycoses | 2003 | 162 |
| 25 | In vitro antimicrobial activity of olive leaves. Antimikrobielle Wirksamkeit von Olivenblattern in vitro | Mycoses | 2003 | 160 |
| 26 | Mucormycosis in India: unique features | Mycoses | 2014 | 151 |
| 27 | A More Sophisticated Method of Determining the Fungicidal Effect of Water‐Insoluble Preparations with a Cell Harvester, Using Miconazole as an Example./Eine verbesserte Methode zur Bestimmung der Fungizidie von wasserunlöslichen Präparaten mit Hilfe eines Zellerntegerätes am Beispiel von Miconazol | Mycoses | 1988 | 150 |
| 28 | Fungal keratitis: An overview of clinical and laboratory aspects | Mycoses | 2018 | 150 |
| 29 | The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis | Mycoses | 2021 | 149 |
| 30 | Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains . Phospholipase- and Protease-Aktivitat bei klinischenCandida-Isolaten mit Bezug zur Herkunft der Stamme | Mycoses | 2002 | 148 |
| 31 | Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity | Mycoses | 2021 | 148 |
| 32 | Antifungal activity of propolis on different species ofCandida | Mycoses | 2001 | 147 |
| 33 | Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis. Verwendung von Punica granatum als Antimykotikum gegen Candidose in Verbindung mit Zahnprothesen-Stomatitis | Mycoses | 2003 | 147 |
| 34 | Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms | Mycoses | 2012 | 146 |
| 35 | Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival | Mycoses | 1999 | 145 |
| 36 | Detection of Aspergillus galactomannan antigen in foods and antibiotics | Mycoses | 1997 | 143 |
| 37 | High prevalence of the neurotropeExophiala dermatitidisand related oligotrophic black yeasts in sauna facilities | Mycoses | 2002 | 143 |
| 38 | Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus | Mycoses | 2016 | 142 |
| 39 | Inhibitory effect of essential oils on apical growth of Aspergillus fumigatus by vapour contact | Mycoses | 2000 | 141 |
| 40 | Dematiaceous fungi | Mycoses | 2007 | 141 |
| 41 | Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole | Mycoses | 1999 | 138 |
| 42 | Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice | Mycoses | 2005 | 138 |
| 43 | Candida auris—the growing menace to global health | Mycoses | 2019 | 138 |
| 44 | The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 ‐ 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studie (1982 ‐ 1987) | Mycoses | 1988 | 137 |
| 45 | COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan | Mycoses | 2020 | 137 |
| 46 | ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries | Mycoses | 2021 | 137 |
| 47 | Antifungal susceptibility of Candida albicans in biofilms | Mycoses | 2012 | 136 |
| 48 | In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin | Mycoses | 1998 | 134 |
| 49 | Rhinocerebral mucormycosis: the disease spectrum in 27 patients | Mycoses | 2007 | 132 |
| 50 | Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata | Mycoses | 2011 | 132 |
